chrisvoncsefalvay/vaers-outcomes huggingface dataset:
solid whole neck rash that was confined to neck and shoulder; This spontaneous case was reported by a consumer and describes the occurrence of RASH (solid whole neck rash that was confined to neck and shoulder) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     The patient's past medical history included Rash from 14-Feb-2021 to 15-Feb-2021.  On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 24-Apr-2021, the patient experienced RASH (solid whole neck rash that was confined to neck and shoulder).   At the time of the report, RASH (solid whole neck rash that was confined to neck and shoulder) outcome was unknown.     This case was linked to US-MODERNATX, INC.-MOD-2021-029248 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes:  On 31-May-2021: No specific follow-up information recorded.
Shaking; Chills; 101 Fever; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 27Apr2021 at 13:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 27Apr2021, the patient experienced 4 hours of shaking chills, 101deg fever which lasted for 24 hours before subsiding. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. On 27Apr2021, the patient underwent body temperature test and the result was 101 degrees(unspecified unit). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shaking and chills were resolved on an unknown date in Apr2021,after the duration of 4 hours while the clinical outcome of the event fever was resolved on 28Apr2021, after a duration of 24 hours.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain a adult female patient who received SHINGRIX. In April 2018, the patient received SHINGRIX. In April 2018, less than a month after receiving SHINGRX, the patient experienced injection site pain, injection site bruising and wrong injection technique. On an unknown date, the outcome of the injection site pain, injection site bruising and wrong injection technique were unknown. The reporter considered the injection site pain and injection site bruising to be unlikely related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The healthcare professional called to make sure he was preparing the SHINGRIX vaccine correctly. The healthcare professional stated that he gave SHINGRIX to the patient 2 weeks before the date of reporting and the patient had bruising and some soreness at the injection site. The healthcare professional felt that was related to his technique and not to the SHINGRIX vaccine itself. The healthcare professional did not want to report this as an adverse event or be contacted further about it. The patient had denied permission to contact their physician.
Patient had an episode of vasovagal syncope about 2 minutes after vaccine administration followed by about 10 seconds of seizure.
Information has been received from a nurse referring to a patient of unknown age and gender. There was no pertinent medical history, concurrent condition, concomitant medication or drug allergy described. On an unspecified date in December 2015, the patient was administered a dose of improperly stored PNEUMOVAX 23 prefilled syringe (PFS) or single-dose vial (SDV) lot # L035686, expiration date unspecified (strength, dose and route were not reported). The vaccine was stored under an unspecified temperature for 3 weeks. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
No other adeverse effects were reported.; patient received a dose of MMR II following a temperature excursion; This spontaneous report was received from an administrator and refers to a patient of an unknown age and gender. No information regarding the patient's concurrent condition, medical history and concomitant medications was provided. On 02-DEC-2019, the patient was vaccinated with a dose of improperly stored (following a temperature excursion) measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), albumin status rHa, lot # R014690, expiration date 23-MAY-2020 (dose and route of administration were not provided) for prophylaxis. No adverse effects were reported. On an unknown date, the temperature was 78 Fahrenheit degrees (26 Celsius degrees) or warmer ( 32 Celsius degrees) for 1 hour and 55 minutes. There was no previous temperature excursion. Data logger was involved.   The outcome of the event were unknown.
extremely sore shoulder muscle for 36 h. low grade fever with whole body ache and chills (onset approx 12 h after injection; duration 12 h).  substantial body fatigue lasting approximately 24 h.  normal health status after approximately 2 days
Hives, wheezing requiring epi pen dose x 1. Improved with epi pen x 1 and observation for 30-40 min.
J&J one shot vaccine-Dizzy/Nauseous/winded easily/Hot to touch but freezing (no temperature)/Sore upper back and shoulders.  Started immediately-then I felt fine until I woke at 3am with more pronounce symptoms
Right after: discomfort in elbow, eye sensitivity  Next day: sore arm, fever (101.5), body aches, severe chills. Third day: sore arm, inflamed lymphnode in left side armpit.
Pt COVID positive on 11/8/2021. PT SOB. DX on admission: NSTEMI (non-ST elevated myocardial infarction) and COVID 19 pneumonitis.    81-year-old female, who presented to hosptial with elevated troponins.  The patient was put on heparin drip and was seen by Cardiology.  She was also found to have COVID-19 pneumonitis. On chest X ray there were multifocal groundglass opacities in each lobe of the lungs. There is developing consolidation at the left lower lobe. There is no pleural effusion.   She was rather asymptomatic on discharge and on room air.  She is feeling well and wanted to go home.  She was cleared by specialists and she was sent home in a stable condition. Discharged to home.
Information has been received from an office manager concerning a 14 year old female patient who in 1998 was vaccinated with the first dose of VARIVAX (Merck).  On 14-SEP-2009 the patient was vaccinated with the second 0.5 ml dose of VARIVAX (Merck) (Lot #664940/0884Y).  Subsequently the patient experienced pain and huge swelling at the injection site and all the way down to fingers and tingling in her fingers.  There were no adverse effects involved for the first dose of VARIVAX (Merck).  The patient had sought unknown medical attention.  At the time of report the patient's status was unknown.  Follow-up information has been received from a physician indicated that a 14 year old female student with no pre-existing allergies, birth defects, medical conditions who was vaccinated with the second dose of VARIVAX (Merck) (Lot # 664940/0884Y) subcutaneously in the right deltoid on 14-SEP-2009.  On 14-SEP-2009 at 21:00PM the patient had a red, indurated, tender area approximately 10 cm surrounding the injection site.  The patient was treated with BONADORM and cool packs.  At the time of report the patient had recovered.  Additional information is not expected.
A medical student reported that an 11 month old female received a 3rd dose of Prevnar vaccine, Haemophilus B conjugate vaccine, Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine absorbed, Hepatitis B vaccine, and Poliomyelitis vaccine inactivated on 4/23/02, when she was 6 months old. Medical history includes seasonal allergies and allergy to carrots. On approximately 9/12/02, the patient developed a fever of 102 degrees with resolved with acetaminophen. Four days later, the patient developed "breathing difficulty". The primary care physician referred her to the ER and she was admitted to the hospital on 9/18/02. She was diagnosed with empyema and pneumonia. She was treated with antibiotics (not specified) and chest x-ray were performed (results not specified). A Thoracentesis produced fluid with pus but not good drainage(10cc). Strep pneumonia was isolated from the blood culture that was sensitive to oxacillin. The patient underwent VATS (video assisted thoraic surgery) on 9/19/02 to drain the remainder of the fluid. On 09/24/02, the patient was diacharged to home. She was seen by a physician on 09/30/02 and doing well. No additional information was avaiable as of the date of this report. No additional information was available as of the date of this report.
approximately one month after receiving second moderna dose, patient experienced sudden tinnitus and overall hearing loss in left ear.  Patient also experiences on and off issues with balance. no other illness was present at the time. patient did have covid infection in november of 2020.  patient went to her primary doctor and was treated first for allergies. one week later followed up and was treating with  antibiotic in case she had an ear infection (even though ear looked normal). after finishing antibiotic, patient was referred to ent. First ent appt in august 2021, hearing test and mri was done. 2nd ent appt oct 2021, another hearing test test.  Patient will be going to a differnt ent doctor for second opinion on 11/8/21.  as of today, symptoms have not improved nor worsened.
PATIENT DENIED RECEIVING ANY OTHER PREVIOUS COVID VACCINE ON CONSENT FORM. WHEN ENTERING VACCINE INTO SYSTEM FOUND OUT THAT HE RECEIVED JANSSEN VACCINE ON 05/03/2021. WHEN CLIENT WAS ASKED ABOUT THIS HE STATED HE HAD RECEIVED THE JANSSEN VACCINE BUT WANTED THE PFIZER SERIES NOW BECAUSE HE DID NOT TRUST THE J&J EFFECTIVENESS ANYMORE.
Lump on the throat. Pt was given Benadryl 25 mg PO. HR 48 (However states that this HR is normal)
My Pigmentation is coming back all over my body and I don't burn in the sun; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as does 2, single for covid-19 immunisation. Relevant medical history included: "I was not able to be in direct sunlight without burning" (unspecified if ongoing), notes: I was not able to be in direct sunlight without burning; "Pigmentation began to return after more than ten years" (unspecified if ongoing), notes: Melanin, which produces my Pigmentation began to return after more than ten years. The patient's concomitant medications were not reported. Vaccination history included: Comirnaty (Dose 1), for COVID-19 immunisation. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "My Pigmentation is coming back all over my body and I don't burn in the sun".  Additional information: it was reported that after the second dose patient Melanin, which produces his Pigmentation began to return after more than ten years. His Pigmentation was completely entirely gone. Patient was not able to be in direct sunlight without burning. Now he could be in direct sunlight without any consequences.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Information has been received from a registered nurse concerning an approximately 74 year old female patient who in 1994 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. The patient reported to the nurse, "When I got the pneumonia shot, it made me sick." Unspecified medical attention was sought, but prescription drug treatment was not required. Subsequently, the patient recovered. A product quality complaint was not involved. Additional information has been requested.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site numbness in a patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site numbness and injection site tingling. On an unknown date, the outcome of the injection site numbness and injection site tingling were unknown. It was unknown if the reporter considered the injection site numbness and injection site tingling to be related to SHINGRIX. Additional details were provided as follows: This case was received via click to chat. The age at vaccination was not reported. No additional information was provided. The pharmacist would not give out demographic background and other information. This case has been linked to US2018052256, reported by the same reporter for the patient who also experienced same adverse events.
Passed out after first shot for 24 hours; Headache after first shot for 24 hours; Extreme body ache after first shot for 24 hours; Fever after first shot for 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (Passed out after first shot for 24 hours), HEADACHE (Headache after first shot for 24 hours), MYALGIA (Extreme body ache after first shot for 24 hours) and PYREXIA (Fever after first shot for 24 hours) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in October 2020. Concurrent medical conditions included Allergy NOS.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced LOSS OF CONSCIOUSNESS (Passed out after first shot for 24 hours), HEADACHE (Headache after first shot for 24 hours), MYALGIA (Extreme body ache after first shot for 24 hours) and PYREXIA (Fever after first shot for 24 hours). In February 2021, LOSS OF CONSCIOUSNESS (Passed out after first shot for 24 hours), HEADACHE (Headache after first shot for 24 hours), MYALGIA (Extreme body ache after first shot for 24 hours) and PYREXIA (Fever after first shot for 24 hours) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No Concomitant medication was reported.    No treatment medications were reported.  It was reported that the symptoms got recovered after 24 hours.   This case was linked to MOD-2021-422844 (Patient Link).
Mother called clinic on 03/04/2010 at 8:45 am and stated that child was complaining that his right arm hurt. Mother notices that right arm from the shoulder to elbow was swollen, warm to touch, red, and itchy. Mother also noticed a rash on the right arm. Child also had a 101 temperature. Mother gave child Tylenol and Benadryl.
This spontaneous report was received from a pharmacist refers to a 75 years old female patient. The patient did not have any drug reactions/allergies. The patient was vaccinated with ZOSTAVAX (lot # reported as 0422AE, expiration date 27-MAR-2013) subcutaneously in the left arm on 15-AUG-2012. No other co-suspects were reported. No concomitant medications were reported. The patient developed an injection site reaction following vaccination with ZOSTAVAX. The pharmacist reported reaction described as a little red area at the injection that was noted during a phone call on 17-AUG-2012 (exact time frame development of the red area was unspecified). The patient came into the pharmacy today (08-OCT-2012) reporting that they still have a red area at the injection site, described as a red area about the size of a quarter (the skin was described as soft, not hard to the touch). No treatment given for adverse event. The outcome of the event was reported as not recovered/resolved. The patient had sought medical attention via contacting pharmacist. No lab diagnosis studies performed. Additional information is not expected.
HEAVINESS OF HEAD; BODY ACHE; CHILLS; This spontaneous report received from a patient concerned a 32 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient was not pregnant. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and expiry: UNKNOWN) dose was not reported, administered on 01-SEP-2021 for prophylactic vaccination. Concomitant medications included metformin.  On 01-SEP-2021, the patient experienced heaviness of head. On 01-SEP-2021, the patient experienced body ache. On 01-SEP-2021, the patient experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from heaviness of head, chills, and body ache. This report was non-serious.
p/vax mom reported excessive crying, which lasted 6 hrs; mom called MD who advised mom to watch temp & wait it out; pt had no problems; pt to recvd DT for future vax;
Weakness, so severe that was in hospital 3 days; Tiredness, questioning if this could be GBS; This case was reported by a consumer via call center representative and described the occurrence of weakness in a 81-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose 0.5ml, intramuscularly in left arm on an unknown date in June 2021).   In October 2021, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On an unknown date, the dose was .5 ml (.5 ml daily). In October 2021, less than a month after receiving Shingrix, the patient experienced weakness (serious criteria hospitalization) and tiredness (serious criteria hospitalization). On an unknown date, the outcome of the weakness and tiredness were not recovered/not resolved.   It was unknown if the reporter considered the weakness and tiredness to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient himself. The patient received his second shot in early October 2021 and by mid-October 2021 following his 2nd vaccine, he experienced weakness and tiredness.   On 31st October 2021, his weakness was so severe that he called and went to the hospital for 3 days.  The patient had no diagnosis for his symptoms and no connection had been made between his weakness and the Shingrix vaccine.  The patient was waiting for an appointment with a neurologist.   The patient's weakness/tiredness has not yet resolved.   The patient questioned whether this could be Guillain-Barre syndrome. The reporter did not consent to follow up.
Incurred rash to one side of body.  Treated self with Zyrtec
rashes started 10 days after from the time booster was administered, rashes appears symmetrical to body areas. I was given a steroid shot on 2/27/22 and was prescribed to take Prednisone 20mg BID x 4 days, Famotidine 20mg 1 tab BID  x 10 days  &, Cetirizine Hydrochloride .Rashes did not fully resolve up to this time, rashes which is very itchy in manner still appears constantly on different body areas even scalp , palms  & foot, breast , groin , body  that becomes warm to touch when started to scratch and appears more at night time.
mom phoned clinic 30NOV92 running temp eve of 26NOV92; next day taken to MD had 1 sz a/MD visit dx w/ear infection; pt had rash onset 27NOV92;
Onset 7 mins. after 2nd dose Gardasil pt. pale, diaphoretic, lightheaded.  After lying flat approx. 15 mins. symptoms subsided.  Vital signs remained stable.  Was released home at 10:35, improved.
Eye dryness progressing to neuropathic type pain localized to the face (left upper face with clear demarcation, same side as injection). At the worst, felt neuropathic pain plus ear pain. Not improved with 1g tylenol and advil. 3 hours later with no improvement, took 10mg prednisone finally offering relief.
Following injection, patient reported arm and hand numbness and feeling "dizzy" and stated they "Felt weird in my head." Patient was given water and noted that they had not eaten anything this morning. Vital signs at 11:30am - Blood pressure :140/80, Heart rate: 80, temperature 99.1, O2 sat: 98% on Room air.  EMS was called. Assessed by EMS, vital signs reassessed by RN at 11:43, standing blood pressure: 150/100, heart rate:82, O2 sat: 98%. Patient released by EMS to home with partner driving car. Patient stated "I will be okay"
On 02/28/2005 patient had labs drawn and was subsequently notified of her elevated liver enzymes.  Medical workup revealed inflammation of liver.  Tests indicated Primary Biliary Cirrhosis.  The subject had a liver biopsy done on 05/18/2005 that indicated autoimmune hepatitis.  Her doctor believes there is a crossover disease process involved.  In May, fluid was noted surrounding her liver within her peritoneal cavity.  80cc of fluid was drained from this area on 06/30/2005.  All tests on this fluid, including cultures, were negative.  Symptoms include right sided pain at waist, fatigue, decreased appetite and sleep disruption due to pain.  Treated with Ursodiol.
Pt received Janseen COVID vaccine.  Pt tested COVID + on 9/22/21 and admitted to hospital for COVID on 10/4/2021. Pt receiving remdesivir and dexamethasone.
p/vax pt exp red, non raised rash extending across chest; as of 8/6 pt still has rash but is diminishing; fever on 8/5; taking benadryl per MD for itch; day 3 sx subsiding
One week following after the vaccination, my arthritis has gotten worse. I'm having cramps in my legs. The cramps in my legs had me go to the doctor. Doctor also notice I had more swelling were my arthritis is. I'm started taking the supplements, calcium, potassium, and magnesium, it's a combination to deal with the leg cramps. And the doctor gave me an osteopathic adjustment. The AE are disabling and impairing my function. I am also having muscle cramps in my abdomen.
Given to patient 17 years of age, under the age of approval for Janssen COVID-19 vaccination.  No adverse effects reported at this time.
Wednesday night I started experiencing pretty severe chills (had happened with dose #2 so I was expecting it). Chills off and on through Thursday. Headaches. Tiredness. At some point Friday I fainted (had not happened before), but do not remember many details. I called a friend to pick me up & take me to walk in clinic. I do not remember much from that visit. My friend would be very happy to provide additional details as my memory is foggy. The gash required 3 stitches which come out Thursday.  I have a black eye, swollen nose (not broken), contusions on both elbows, and a huge bruise on one hip. My permanent damage will be an unsightly scar across my forehead.